Structural and energetic insight into the isoform-selective inhibitors of tumour marker Hsp90 against Grp94

References

• Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010;11:515–528.
   PubMed Web of Science ®Google Scholar
• Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, Krogan N, Cagney G, Mai D, Greenblatt J, Bonne C, Emili A, Houry WA. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell. 2005;120:715–727.
   PubMed Web of Science ®Google Scholar
• Mazzarella RA, Green M. ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GPR94). J Biol Chem. 1987;262:8875–8883.
   PubMed Web of Science ®Google Scholar
• Khalil AA, Kabapy NF, Deraz SF, Smith C. Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta. 2011;1816:89–104.
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Guan S, Fan J, Cheng CF, Bright AM, Chinn C, Chen M, Woodley DT. Extracellular heat shock protein-90 alpha: linking hypoxia to skin cell motility and wound healing. EMBO J. 1007;26:1221–1233.
   Google Scholar
• Wang X, Song X, Zhuo W, Fu Y, Shi H, Liang Y, Tong M, Chang G, Luo Y. The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy. Proc Natl Acad Sci USA. 2009;106:21288–21293.
   PubMed Web of Science ®Google Scholar
• Shiau AK, Harris SF, Southworth DR, Agard DA. Structural analysis of e. coli Hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell. 2006;127:329–340.
   PubMed Web of Science ®Google Scholar
• Lu S, Li S, Zhang J. Harnessing allostery: a novel approach to drug discovery. Med Res Rev. 2014;34:1242–1285.
   PubMed Web of Science ®Google Scholar
• Lu S, Huang W, Zhang J. Recent computational advances in the identification of allosteric sites in proteins. Drug Discov Today. 2014;19:1595–1600.
   PubMed Web of Science ®Google Scholar
• Lu S, Huang W, Wang Q, Shen Q, Li S, Nussinov R, Zhang J. The structural basis of ATP as an allosteric modulator. PLoS Comput Biol. 2014;10:e1003831.
   PubMed Web of Science ®Google Scholar
• Fierro-Monti I, Echeverria P, Racle J, Hernandez C, Picard D, Quadroni M. Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy. PLoS ONE. 2013;8:e80425.
   PubMed Web of Science ®Google Scholar
• Huryn DM, Resnick LO, Wipf P. Contributions of academic laboratories to the discovery and developments of chemical biology tools. J Med Chem. 2013;56:7161–7176.
   PubMed Web of Science ®Google Scholar
• Giubellino A, Sourbier C, Lee MJ, Scroggins B, Bullova P, Landau M, Ying W, Neckers L, Trepel JB, Pacak K. Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. PLoS ONE. 2013;8:e56083.
   PubMed Web of Science ®Google Scholar
• Brasca MG, Mantegani S, Amboldi N, Bindi S, Caronni D, Casale E, Ceccarelli W, Colombo N, Ponti AD, Donati D, Ermoli A, Fachin G, Felder ER, Ferguson RD, Fiorelli C, Guanci M, Isacchi A, Pesenti E, Polucci P, Riceputi L, Sola F, Visco C, Zuccotto F, Fogliatto G. Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90). Bioorg Med Chem. 2013;21:7047–7063.
   PubMed Web of Science ®Google Scholar
• Ernst JT, Neubert T, Liu M, Sperry S, Zuccola H, Turnbull A, Fleck B, Kargo W, Woody L, Chiang P, Tran D, Chen W, Snyder P, Alcacio T, Nezami A, Reynolds J, Alvi K, Goulet L, Stamos D. Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease. J Med Chem. 2014;57:3382–3400.
   PubMed Web of Science ®Google Scholar
• Wright L, Barril X, Dymock B, Sheridan L, Surgenor A, Beswick M, Drysdale M, Collier A, Massey A, Davies N, Fink A, Fromont C, Aherne W, Boxall K, Sharp S, Workman P, Hubbard RE. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem Biol. 2004;11:775–785.
   PubMed Web of Science ®Google Scholar
• Immormino RM, Metzger LE IV, Reardon PN, Dollins DE, Blagg BSJ, Gewirth DT. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design. J Mol Biol. 2009;388:1033–1042.
   PubMed Web of Science ®Google Scholar
• Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T. SWISS-MODEL: modeling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252–W258.
   PubMed Web of Science ®Google Scholar
• Tippani R, Prakhya LJ, Porika M, Sirisha K, Abbagani S, Thammidala C. Pterostilbene as a potential novel telomerase inhibitor: molecular docking studies and its in vitro evaluation. Curr Pharm Biotechnol. 2014;14:1027–1035.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785–2791.
   PubMed Web of Science ®Google Scholar
• Lu S, Huang W, Li X, Huang Z, Liu X, Chen Y, Shi T. Zhang J Insights into the role of magnesium traid in myo-inositol monophosphatase: metal mechanism, substrate binding, and lithium therapy. J Chem Inf Model. 2012;52:2398–2409.
   PubMed Web of Science ®Google Scholar
• Lu S-Y, Jiang Y-J, Lv J, Zou J-W, Wu T-X. Role of bridging water molecules in GSK3β-inhinitor complexes: insights from QM/MM, MD, and molecular docking studies. J Comput Chem. 2011;32:1907–1918.
   PubMed Web of Science ®Google Scholar
• Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts BP, Wang B, Hayik S, Roitberg A, Seabra G, Kolossvary I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA, AMBER 11. University of California: San Francisco ; 2010.
   Google Scholar
• Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T. A point-charge force field for molecular mechanics simulations of proteins. J Comput Chem. 2003;24:1999–2012.
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157–1174.
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of single potential function for simulating liquid water. J Chem Phys. 1983;79:926–935.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092.
   Web of Science ®Google Scholar
• Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1997;23:327–341.
   Web of Science ®Google Scholar
• Wu X, Brooks BR. Self-guided Langevin dynamics simulation method. Chem Phys Lett. 2003;381:512–518.
   Web of Science ®Google Scholar
• Sun H, Li Y, Tian S, Wang J, Hou T. P-loop conformation governed crizotinib resistance in G2032R-mutated ROS1 tyrosine kinase: clues from free energy landscape. PLoS Comput Biol. 2014;10:e1003729.
   PubMed Web of Science ®Google Scholar
• Zhang J-L, Zheng Q-C, Li Z-Q, Zhang H-X. Theoretical evaluation and improvement on the potency of the rhodanine-based inhibitors for human serotonin N-acetyltransferase. Mol Sim. 2014;40:1201–1208.
   Web of Science ®Google Scholar
• Wichapong K, Nueangaudom A, Pianwanit S, Tanaka F, Kokpol S. Molecular dynamics simulation, binding free energy calculation and molecular docking of human d-amino acid oxidase (DAAO) with its inhibitors. Mol Sim. 2014;40:1167–1189.
   Web of Science ®Google Scholar
• Bai Q, Pérez-Sánchez H, Zhang Y, Shao Y, Shi D, Liu H, Yao Y. Ligand induced change of β2 adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analysis. Phys Chem Chem Phys. 2014;16:15874–15885.
   PubMed Web of Science ®Google Scholar
• Lu S-Y, Jiang Y-J, Zou J-W, Wu T-X. Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substarte complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates. J Chem Inf Model. 2011;51:1025–1036.
   PubMed Web of Science ®Google Scholar
• Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33:889–897.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 2011;51:69–82.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. 2. The accuracy of ranking poses generalized from docking. J Comput Chem. 2011;32:866–877.
   PubMed Web of Science ®Google Scholar
• Xu L, Sun H, Li Y, Wang J, Hou T. Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. J Phys Chem B. 2013;117:8408–8421.
   PubMed Web of Science ®Google Scholar
• Sun H, Li Y, Tian S, Xu L, Hou T. Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys. 2014;16:16719–16729.
   PubMed Web of Science ®Google Scholar
• Gohlke H, Kiel C, Case DA. Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol. 2003;330:891–913.
   PubMed Web of Science ®Google Scholar
• Hou T, Li N, Li Y, Wang W. Characterization of domain–peptide interaction interface: prediction of SH3 domain-mediated protein–protein interaction network in yeast by generic structure-based models. J Proteome Res. 2012;11:2982–2995.
   PubMed Web of Science ®Google Scholar
• Hou T, Zhang W, Case DA, Wang W. Characterization of domain–peptide interaction interface: a case study on the amphiphysin-1 SH3 domain. J Mol Biol. 2008;376:1201–1214.
   PubMed Web of Science ®Google Scholar
• Wang J, Hou T, Xu X. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Curr Comput Aided Drug Des. 2006;2:287–306.
   Web of Science ®Google Scholar
• Hou T, Yu R. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. J Med Chem. 2007;50:1177–1188.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Tian Z, Zhao H, Liang D, Li W, Qiu Y, Lu S. Structural basis of valmerins as dual inhibitors of GSK3β/CDK5. J Mol Model. 2014;20:2407.
   PubMed Web of Science ®Google Scholar